We advised BioGeneration Ventures and regional development agency InnovationQuarter on their seed investment in VarmX B.V., a spin-out company of the Leiden University Medical Center in the Netherlands. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients.